You are required to be logged in to access the full website
Click here if you have forgotten your username or password
20 July 2026 - Biotechnology company Sareum Holdings plc (AIM: SAR) announced on Monday that it has completed dosing in the Phase 2-enabling toxicology programme for SDC-1801, its selective oral TYK2/JAK1 inhibitor being developed for autoimmune dise...
20 July 2026 - Biopharmaceutical company GSK plc (LSE: GSK) (NYSE: GSK) reported on Monday that the European Medicines Agency has accepted its submission to update the Bexsero label to include a single booster dose for individuals aged 10 years and o...
20 July 2026 - Digital health and pharmacy group MedPal AI plc (AIM: MPAL) (FRA: Z1N) announced on Monday that it has acquired Solid State Technologies Ltd, trading as eMARx, a provider of electronic medication administration record software for UK c...
20 July 2026 - Kibow Biotech, a developer of probiotic supplements for maintaining kidney health, announced on Friday that it has been named the recipient of The American Association of Naturopathic Physicians (AANP) Corporation of the Year Award.Pre...
20 July 2026 - Evaxion A/S, a Denmark-based, clinical-stage TechBio company developing novel vaccines with its AI-Immunology platform, said on Friday that it will present three-year clinical efficacy data from its phase 2 trial with personalised canc...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe